Sponsor Pipeline

First Affiliated Hospital of Chongqing Medical University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
44
Active Trials
21
Recruiting
10
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-21 NCT07717697 Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy… Not Yet Recruiting
Active Trials by Phase
Phase 4
1
Phase 2
4
Phase 1/2
2
Phase 1
2
Early Phase 1
3
Not specified
32
Active Trials — top 25 of 44
NCT IDTitleConditionStatus
Phase 4
NCT07133438 Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion… Retinal Vein Occlusion (RVO) Recruiting
Phase 2
NCT07645157 Sertraline Combined With Multi-Strain Probiotics for Adolescent Depression Major Depressive Disorder (MDD) Recruiting
NCT07539805 Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents… Major Depressive Disorder (MDD) Recruiting
NCT07203144 Selenium Supplementation for Improving Depression in Children and Adolescents: Efficacy… Depression - Major Depressive Disorder Not Yet Recruiting
NCT07324473 Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced… Hepatocellular Carcinomas Not Yet Recruiting
Phase 1/2
NCT07275632 The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients Delayed Graft Function Recruiting
NCT05814640 Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) Depression Recruiting
Phase 1
NCT06766266 Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder… Non-Muscle Invasive Bladder Urothelial Carcinoma Recruiting
NCT06916494 Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as… Muscle Invasive Bladder Cancer Recruiting
Early Phase 1
NCT06387381 68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease PSMA Recruiting
NCT06419348 99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer Prostate Cancer Stage Recruiting
NCT06419361 [68Ga]Ga-Sa-DABI-4 PET Imaging of Stimulator of Interferon Gene Expression in Cancer… Stimulator of Interferon Gene Recruiting
Not specified
NCT06507683 Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the… Gastrointestinal Stromal Tumors Recruiting
NCT06524037 Relationship Between Metabolic Profiles and Chronic Diseases and Neoplasms Metabolic Diseases Recruiting
NCT06463756 AI Models to Predict Thyroid Cartilage Invasion in Laryngeal Carcinoma Laryngeal Carcinoma Recruiting
NCT06730711 Association Between Blood Pressure and Risk of PSCI Stroke Recruiting
NCT06826573 Analysis of Risk Factors for High Intraocular Pressure and Retinal Detachment Recurrence… Rhegmatogenous Retinal Detachment Recruiting
NCT06092450 Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive… Bladder Cancer Recruiting
NCT07027280 Noninvasive Intratumor Heterogeneity Evaluation in HNSCC Head and Neck Cancer Recruiting
NCT07163013 Digital Cognitive Behavioral Therapy for Chinese Adolescents With Depressive… Depressive Symptom Recruiting
NCT07461467 Effects of Continuous Monitoring and Progressive Regulation of Inflatable Laryngeal Mask… Elderly (People Aged 65 or More) Recruiting
NCT06275516 Safety and Efficacy of Multisensory Stimulation Virtual Reality for Stroke Patients. Stroke Recruiting
NCT07185438 Feasibility, Safety, and Preliminary Clinical Efficacy of Magnetic Resonance… Depression - Major Depressive Disorder Recruiting
NCT06606912 Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on… Gastric Cancers Active, Not Recruiting
NCT06614660 Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer Colorectal Cancer Active, Not Recruiting
See all 44 active First Affiliated Hospital of Chongqing Medical University trials with filters →
Disease Areas
Get alerts when First Affiliated Hospital of Chongqing Medical University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free